WO2025172958 - SOLID STATE FORMS OF RESMETIROM
National phase entry is expected:
Publication Number
WO/2025/172958
Publication Date
21.08.2025
International Application No.
PCT/IB2025/051665
International Filing Date
15.02.2025
Title **
[English]
SOLID STATE FORMS OF RESMETIROM
[French]
FORMES À L'ÉTAT SOLIDE DE RESMÉTIROM
Applicants **
METROCHEM API PVT LTD
Inventors
NANDEPU, Venkateswara Rao
NANDEPU, Hardev
SOMISETTI, Narender Rao
VEEDHI, Srinivasarao
NEKKANTI, Satish Chowdary
Priority Data
202441011020
16.02.2024
IN
202441030737
17.04.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2360 | |
| EPO | Filing, Examination, Granting | 15120 | |
| Japan | Filing, Examination, Granting | 2370 | |
| South Korea | Filing, Examination, Granting | 2629 | |
| USA | Filing, Examination, Granting | 9940 |

Total:
32,419
Contact Us
Abstract[English]
The present invention relates to crystalline and amorphous form of Resmetirom, process for their preparation as well as their pharmaceutical composition.[French]
La présente invention concerne des formes cristallines et amorphes de resmétirom, un procédé pour leur préparation ainsi qu'une composition pharmaceutique correspondante.